Bluejay Diagnostics, Inc. Increase (Decrease) in Prepaid Expenses, Other
Bluejay Diagnostics, Inc. (BJDX) reported Increase (Decrease) in Prepaid Expenses, Other of $40.77 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-20.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpensesOther · last filed 2023-03-20
- Bluejay Diagnostics, Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2022-12-31 was $1.01M, a 19.22% decline year-over-year.
- Bluejay Diagnostics, Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2022-09-30 was -$390.25K, a 229.16% decline year-over-year.
- Bluejay Diagnostics, Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2022-06-30 was -$265.61K, a 6405.91% decline year-over-year.
- Bluejay Diagnostics, Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2022-03-31 was -$309.96K.
- Bluejay Diagnostics, Inc. increase (decrease) in prepaid expenses, other for fiscal 2022 was $40.77K, a 97.37% decline from fiscal 2021.
- Bluejay Diagnostics, Inc. increase (decrease) in prepaid expenses, other for fiscal 2021 was $1.55M.
- Bluejay Diagnostics, Inc. increase (decrease) in prepaid expenses, other for fiscal 2020 was -$19.11K.
| Period end | Increase (Decrease) in Prepaid Expenses, Other 3 month | Increase (Decrease) in Prepaid Expenses, Other 6 month | Increase (Decrease) in Prepaid Expenses, Other 9 month | Increase (Decrease) in Prepaid Expenses, Other 9 month as first filed | Increase (Decrease) in Prepaid Expenses, Other 12 month |
|---|---|---|---|---|---|
| 2022-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $616.34K derived: sum of 2 quarters · filed 2023-03-20 | $350.73K derived: sum of 3 quarters · filed 2023-03-20 | $40.77K 10-K · filed 2023-03-20 | |
| 2022-09-30 | -$390.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$655.86K derived: sum of 2 quarters · filed 2022-11-09 | -$965.81K 10-Q · filed 2022-11-09 | $280.25K derived: sum of 4 quarters · filed 2023-03-20 | |
| 2022-06-30 | -$265.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$575.56K 10-Q · filed 2022-08-10 | $670.50K derived: sum of 3 quarters · filed 2023-03-20 | $972.65K derived: sum of 4 quarters · filed 2023-03-20 | |
| 2022-03-31 | -$309.96K 10-Q · filed 2022-05-09 | $936.11K derived: sum of 2 quarters · filed 2023-03-20 | $1.24M derived: sum of 3 quarters · filed 2023-03-20 | $1.24M derived: sum of 4 quarters · filed 2023-03-20 | |
| 2021-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $1.55M derived: sum of 2 quarters · filed 2023-03-20 | $1.55M derived: sum of 3 quarters · filed 2023-03-20 | $1.55M 10-K · filed 2023-03-20 | |
| 2021-09-30 | $302.15K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $306.36K derived: sum of 2 quarters · filed 2022-11-09 | $305.57K 10-Q · filed 2022-11-09 | $390.34K 10-Q · filed 2021-12-16 | $304.79K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $4.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $3.42K 10-Q · filed 2022-08-10 | $2.64K derived: sum of 3 quarters · filed 2022-08-10 | ||
| 2021-03-31 | -$787.00 10-Q · filed 2022-05-09 | -$1.57K derived: sum of 2 quarters · filed 2022-05-09 | |||
| 2020-12-31 | -$788.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$19.11K 10-K · filed 2022-03-10 | |||
| 2020-09-30 | -$18.32K 10-Q · filed 2021-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |